{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:58:04Z","timestamp":1781567884722,"version":"3.54.5"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fosfomycin combined with other antibiotics is often used to treat\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      infections. In this study, we investigated the effects of fosfomycin and azithromycin as monotherapy and combination therapy on the metabolic changes of multidrug-resistant\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Multidrug-resistant\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      was exposed to fosfomycin, azithromycin, or their combination. Non-targeted metabolomic profiling was performed using LC\u2013MS\/MS. Differential metabolites were identified statistically using Student\u2019s t-test, with significance defined as p &amp;lt; 0.05 and log\n                      <jats:sub>2<\/jats:sub>\n                      fold change (log\n                      <jats:sub>2<\/jats:sub>\n                      FC) \u2265 1 or \u2264 \u22121.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The minimum inhibitory concentration was 32\/4 \u03bcg\/mL for fosfomycin\/azithromycin combination against the\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      strain evaluated for metabolomic changes. Metabolomic analysis showed that the combination therapy resulted in greater disturbances affecting the abundance and content levels of metabolites of\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      than monotherapies. The affected metabolic pathways were mainly amino acid metabolism, nucleotide metabolism, carbohydrate metabolism and lipid metabolism, among which nucleotide metabolism was most significantly disturbed. In the nucleotide metabolism, purine metabolism was affected more than pyrimidine metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Fosfomycin\u2013azithromycin combination therapy exerted stronger interference on the metabolic pathways of\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      than either drug alone, indicating more substantial metabolic alterations at the cellular level. These findings provide mechanistic insights that may help inform the potential application of combination regimens against multidrug-resistant\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      in the clinic.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1663542","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:19Z","timestamp":1761111139000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomics reveals the mechanisms of action of fosfomycin and azithromycin combination in the treatment of Pseudomonas aeruginosa"],"prefix":"10.3389","volume":"15","author":[{"given":"Ziyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwin K. B.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00126-19","article-title":"Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-beta-Lactamase","volume":"63","author":"Albiero","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1128\/AAC.03099-15","article-title":"Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae","volume":"60","author":"Albiero","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1574-6976.2008.00104.x","article-title":"Cytoplasmic steps of peptidoglycan biosynthesis","volume":"32","author":"Barreteau","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2006.02.016","article-title":"Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry","volume":"352","author":"Bleijerveld","year":"2006","journal-title":"Anal. Biochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040592","article-title":"Nucleotide metabolism","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molcatb.2008.06.005","article-title":"Preparative scale enzymatic synthesis of d-sedoheptulose-7-phosphate from \u03b2-hydroxypyruvate and d-ribose-5-phosphate","volume":"57","author":"Charmantray","year":"2009","journal-title":"J. Mol. Catal. B: Enzym."},{"key":"B8","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"CLSI document M100.","year":"2024"},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02498-16","article-title":"Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities","volume":"61","author":"Fedrigo","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13756-021-00977-w","article-title":"Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study","volume":"10","author":"Feng","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B12","doi-asserted-by":"publisher","first-page":"14429","DOI":"10.1038\/s41598-023-39647-9","article-title":"In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae","volume":"13","author":"Gomara-Lomero","year":"2023","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jcf.2004.09.001","article-title":"Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study","volume":"4","author":"Hansen","year":"2005","journal-title":"J. Cyst Fibros"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.26599\/fshw.2024.9250075","article-title":"Sesamol: a novel quorum sensing inhibitor and colistin accelerator against Pseudomonas aeruginosa","volume":"14","author":"Ji","year":"2025","journal-title":"Food Sci. Hum. Wellness"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1517\/14656566.2014.914172","article-title":"Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches","volume":"15","author":"Karaiskos","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114154","article-title":"Environmental purines decrease Pseudomonas aeruginosa biofilm formation by disrupting c-di-GMP metabolism","volume":"43","author":"Kennelly","year":"2024","journal-title":"Cell Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1128\/JB.184.2.363-369.2002","article-title":"Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia coli","volume":"184","author":"Kneidinger","year":"2002","journal-title":"J. Bacteriol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.603151","article-title":"Azithromycin exhibits activity against pseudomonas aeruginosa in chronic rat lung infection model","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.583468","article-title":"Digital insights into nucleotide metabolism and antibiotic treatment failure","volume":"3","author":"Lopatkin","year":"2021","journal-title":"Front. Digit Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1128\/AAC.00349-11","article-title":"Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods","volume":"55","author":"Lu","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/srep45527","article-title":"Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii","volume":"7","author":"Maifiah","year":"2017","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","article-title":"Clinical and histologic features of azithromycin-induced liver injury","volume":"13","author":"Martinez","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107134","article-title":"Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience","volume":"63","author":"Meschiari","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2023.100030","article-title":"Phage therapy as a revolutionary treatment for multidrug-resistant Pseudomonas aeruginosa infections: A narrative review","volume":"2","author":"Nawaz","year":"2024","journal-title":"Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","author":"Oliver","year":"2015","journal-title":"Drug Resist. Update"},{"key":"B27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.drudis.2017.11.001","article-title":"Fixed-dose combinations: a potential means to boost drug development for selected drugs","volume":"23","author":"Oo","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drudis.2019.07.012","article-title":"Learning and augmenting natural processes: potential means of combating antimicrobial resistance from a drug R&D perspective","volume":"25","author":"Oo","year":"2020","journal-title":"Drug Discov. Today"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103674","article-title":"Evaluating the status of antibiotic approvals and readiness to combat antimicrobial resistance: What else can we do better","volume":"28","author":"Oo","year":"2023","journal-title":"Drug Discov. Today"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1128\/AAC.01628-08","article-title":"Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms","volume":"53","author":"Presterl","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","article-title":"Fosfomycin: an old\u2013new antibiotic","volume":"18","author":"Raz","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29798","article-title":"Pseudomonas aeruginosa and related antibiotic resistance genes as indicators for wastewater treatment","volume":"10","author":"Reem","year":"2024","journal-title":"Heliyon"},{"key":"B34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","article-title":"Fosfomycin: Resurgence of an old companion","volume":"22","author":"Sastry","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1021\/jp0704822","article-title":"Effect of unsaturation in fatty acids on the main characteristics of langmuir monolayers","volume":"111","author":"Vollhardt","year":"2007","journal-title":"J. Phys. Chem. C"},{"key":"B37","first-page":"753","article-title":"Chapter 41 - Pseudomonas aeruginosa","volume-title":"Molecular Medical Microbiology (Second Edition)","author":"Wu","year":"2015"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1024702","article-title":"The combination effect of meropenem\/sulbactam\/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/pharmaceutics15010251","article-title":"Pharmacokinetic\/Pharmacodynamic Evaluation of Aztreonam\/Amoxicillin\/Clavulanate Combination against New Delhi Metallo-beta-Lactamase and Serine-beta-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0075823","DOI":"10.1128\/msystems.00758-23","article-title":"Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant Escherichia coli","volume":"8","author":"Zhang","year":"2023","journal-title":"mSystems"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.26599\/fmh.2024.9420001","article-title":"Anti-virulence potential of carvone against Serratia marcescens","volume":"1","author":"Zhou","year":"2024","journal-title":"Food Med. Homology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1217270","article-title":"Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1013934","article-title":"Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.carres.2013.03.005","article-title":"One-pot three-enzyme synthesis of UDP-Glc, UDP-Gal, and their derivatives","volume":"373","author":"Zou","year":"2013","journal-title":"Carbohydr Res."},{"key":"B45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/9781119991311.ch5","article-title":"Nucleotide metabolism","volume-title":"Plant Metabolism and Biotechnology.","author":"Zrenner","year":"2011"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1663542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:20Z","timestamp":1761111140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1663542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2025.1663542"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1663542","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1663542"}}